Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

APO-DABIGATRAN DIN 02468905

Status: Marketed
Holder: APOTEX INC
Molecule: DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE)
Available to quote

Health Canada record

Active ingredient(s)DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MG
Dosage formCapsule
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCB01AE07 DABIGATRAN ETEXILATE
Original market date04-Feb-2019
Current status date05-Oct-2022
SourceHealth Canada DPD

Establishment licence of the holder

Apotex Inc — licence 100375, currently licensed, last inspection rating C (2026-04-21).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing DABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE)

DINProductCompanyFormStrengthStatus
02468891APO-DABIGATRANAPOTEX INCCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGMarketed
02468913APO-DABIGATRANAPOTEX INCCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGMarketed
02358808PRADAXABOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGMarketed
02312441PRADAXABOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 110 MGMarketed
02312433PRADAXABOEHRINGER INGELHEIM (CANADA) LTD LTEECapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGCancelled Post Market
02463458TEVA-DABIGATRANTEVA CANADA LIMITEDCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 75 MGCancelled Pre Market
02463466TEVA-DABIGATRANTEVA CANADA LIMITEDCapsuleDABIGATRAN ETEXILATE (DABIGATRAN ETEXILATE MESILATE) 150 MGCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
205012018-02-19Abbreviated New Drug Submission (ANDS)
Request a quote for APO-DABIGATRAN

How to read a Canadian DIN record